Thinking critically about the value and cost of drugs: managing patients with invasive fungal disease
How can European countries improve cervical cancer prevention for women?
Exploring the value of a rapid, on-demand test for the detection of human papillomavirus
Understanding Idiopathic Pulmonary Fibrosis patient care delivery and costs
We explored patient pathways for the diagnosis, management and monitoring of idiopathic pulmonary fibrosis (IPF) across England, based on NICE pathways, and interviews with healthcare staff from 14 hospital trusts. Data were used in our in-house tool to estimate the cost of pathways, compared to tariff reimbursement. We found large variation across England in how services for IPF patients are delivered, variation compared to the NICE pathway, and costs >40% more than what is currently reimbursed.
The benefits and cost-savings of a new point-of-care test for chlamydia and gonorrhoea
We developed an understanding of how sexual health clinics in England could use a rapid point of care test for two common sexually transmitted infections. We defined the current patient care pathways and found that the pathways could be streamlined and costs of care reduced by using point-of-care tests. The economic model developed by Aquarius Population Health showed that the test could deliver ÂŁ10 million in cost savings, and give far more effective management of chlamydia and gonorrhoea at a population level.
Benefits of a point of care test for sexual health testing
Managing Mycoplasma genitalium as an STI
Point-of-care testing leads the way: article in the Parliamentary Review 2014
Mapping patient pathways and cost of point of care versus standard testing and treatment for chlamydia and gonorrhoea in sexual health clinics
The cost and tariff reimbursement of idiopathic pulmonary fibrosis in England
